Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Antimicrobial Agents and Chemotherapy
|
July 22, 2009
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis
Deepak Almeida, Eric Nuermberger, Rokeya Tasneen, et al.
Plos One
|
July 9, 2014
Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis
George L Drusano, Michael Neely, Michael Van Guilder, et al.
Clinical Therapeutics
|
October 9, 2020
A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis
Boi-Lam Hong, Ronilda D'Cunha, Peizhi Li, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 18, 2017
Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia
Nilay Thakkar, Jeffrey T Guptill, Kathy Aleš, et al.
Clinical Pharmacokinetics
|
January 26, 2020
Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis
Ruben van der Galiën, Natasha Van't Boveneind-Vrubleuskaya, Charles Peloquin, et al.
Journal of Pharmaceutical Sciences
|
November 16, 2016
Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs
Lucila Garcia-Contreras, Danielle J Padilla-Carlin, Jean Sung, et al.
Thescientificworldjournal
|
February 24, 2006
Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendations
Subramanian Vaidyanathan, Charles Peloquin, Jean-Jacques Wyndaele, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model
G L Drusano, Jenny Myrick, Michael Maynard, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Activity of Moxifloxacin against <i>Mycobacterium tuberculosis</i> in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model
Arnold Louie, Brandon Duncanson, Jenny Myrick, et al.
Jac-Antimicrobial Resistance
|
January 23, 2024
Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy
Veena Venugopalan, Nicole Maranchick, Devorah Hanai, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Antimicrobial Agents and Chemotherapy
|
July 22, 2009
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis
Deepak Almeida, Eric Nuermberger, Rokeya Tasneen, et al.
Plos One
|
July 9, 2014
Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis
George L Drusano, Michael Neely, Michael Van Guilder, et al.
Clinical Therapeutics
|
October 9, 2020
A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis
Boi-Lam Hong, Ronilda D'Cunha, Peizhi Li, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 18, 2017
Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia
Nilay Thakkar, Jeffrey T Guptill, Kathy Aleš, et al.
Clinical Pharmacokinetics
|
January 26, 2020
Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis
Ruben van der Galiën, Natasha Van't Boveneind-Vrubleuskaya, Charles Peloquin, et al.
Journal of Pharmaceutical Sciences
|
November 16, 2016
Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs
Lucila Garcia-Contreras, Danielle J Padilla-Carlin, Jean Sung, et al.
Thescientificworldjournal
|
February 24, 2006
Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendations
Subramanian Vaidyanathan, Charles Peloquin, Jean-Jacques Wyndaele, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model
G L Drusano, Jenny Myrick, Michael Maynard, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Activity of Moxifloxacin against <i>Mycobacterium tuberculosis</i> in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model
Arnold Louie, Brandon Duncanson, Jenny Myrick, et al.
Jac-Antimicrobial Resistance
|
January 23, 2024
Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy
Veena Venugopalan, Nicole Maranchick, Devorah Hanai, et al.
Page
of 3